Explore UAB

CCTS Impact - Research Success Stories

A single study can ripple far beyond the lab, leading to new diagnostics, treatments, or clinical practices that change how care is delivered. These stories trace that journey, from a CCTS-supported research question to a tangible outcome that improves patient care.
CCTS ImpactProgram Success StoriesEntrepreneurship StoriesIndividual Career Stories

Link to Publication

 

Abstract

The study demonstrates that neurons within the tumor microenvironment transfer mitochondria to breast cancer cells, enhancing their metabolic flexibility and metastatic potential. Cancer cells need enormous amounts of energy to grow and spread. This study reveals a surprising mechanism: cancer cells physically interact with nearby nerves and pull mitochondria — the cell’s “power generators” — directly from them. Once inside the cancer cell, these borrowed mitochondria boost energy production, helping tumors grow faster and invade new tissues. The research identifies the molecular machinery that enables this transfer and shows that blocking the process slows cancer progression. This discovery opens new possibilities for therapies that target the metabolic “fuel lines” between nerves and tumors.


22% Reduction in major adverse pregnancy outcomes 19% Reduction in preeclampsia 12% Reduction in preterm birth

Impact Story

"Cancer metastasis is responsible for most cancer‑related deaths, yet scientists still struggle to understand how tumors gain the energy needed to spread. This research uncovers a previously unknown biological interaction: nerves surrounding a tumor can donate their mitochondria to cancer cells. These transferred mitochondria act like a power‑up, giving cancer cells the extra energy required to survive, grow, and invade other organs.

By identifying the proteins and pathways that allow mitochondria to move from nerves to cancer cells, the study provides a new therapeutic target. Instead of only trying to kill cancer cells directly, future treatments could disrupt the energy supply chain that tumors rely on. This shift in strategy could lead to drugs that slow or prevent metastasis by blocking mitochondrial transfer — a major advance for patients with aggressive cancers.

The work also highlights the importance of the tumor microenvironment. Nerves are not just passive bystanders; they actively contribute to cancer progression. Understanding this relationship may help clinicians predict which tumors are more likely to metastasize and tailor treatments accordingly."


TSBM Benefit

Clinical and Medical Benefit

  • Diagnostic Procedures: Identifies a new therapeutic target: blocking mitochondrial transfer.
  • Therapeutic Procedures: Potential to reduce metastasis, the leading cause of cancer mortality.
  • Clinical Innovation Access: Enables more personalized treatment based on tumor microenvironment features.

Benefits Community

Community & Public Health Benefits

  • Disease Prevention & Reduction: Advances understanding of metastasis, benefiting millions of cancer patients.
  • Healthcare Accessibility: Mechanistic insights can support equitable access to emerging therapies.
  • Healthcare Quality: Supports development of new strategies for aggressive cancers.

Benefits Economic

Economic Benefits

Cost Savings: Preventing metastasis reduces expensive late‑stage cancer care.